Viral replication and the coactivators p300 and CBP

Trends in Microbiology

Volumn 8, Issue 12, 2000, Pages 560-565

  Hottiger, Michael O ^a   Nabel, Gary J ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; CYCLIC AMP BINDING PROTEIN; PROTEIN; PROTEIN P300; REGULATOR PROTEIN; TRANSFORMING PROTEIN; VIRUS PROTEIN;

CELL CYCLE; CELL TRANSFORMATION; DNA TUMOR VIRUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN T CELL LEUKEMIA VIRUS 1; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALS; CELL TRANSFORMATION, VIRAL; CREB-BINDING PROTEIN; DNA TUMOR VIRUSES; GENE EXPRESSION REGULATION, VIRAL; HISTONE ACETYLTRANSFERASES; HUMANS; LENTIVIRUS; MICE; NUCLEAR PROTEINS; TRANS-ACTIVATORS; VIRUS REPLICATION;

TUMOR VIRUS;

EID: 0034547922     PISSN: 0966842X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-842X(00)01874-6     Document Type: Review

References (41)

1. Cellular targets for transformation by the adenovirus E1A proteins
2. Association of p300 and CBP with simian virus 40 large T antigen
3. Phosphorylated CREB binds specifically to the nuclear protein CBP
4. Transcriptional control: versatile molecular glue
5. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A
6. Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300
7. Two regions of the adenovirus early region 1A proteins are required for transformation
8. Definition of the minimal simian virus 40 large T antigen- and adenovirus E1A-binding domain in the retinoblastoma gene product
9. Nuclear protein CBP is a coactivator for the transcription factor CREB
10. Viral transactivating proteins
11. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity
12. WAF1, a potential mediator of p53 tumor suppression
13. Binding and modulation of p53 by p300/CBP coactivators
14. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain
15. Characterization of an E1A-CBP interaction defines a novel transcriptional adapter motif (TRAM) in CBP/p300
16. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
17. E1A directly binds and regulates the P/CAF acetyltransferase
18. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A
19. The CBP co-activator is a histone acetyltransferase
20. Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A
21. Hyperphosphorylated p107 and p130 bind to T-antigen: identification of a critical regulatory sequence present in RB but not in p107/p130
22. Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products
23. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300
24. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
25. The amino-terminal C/H1 domain of CREB binding protein mediates zta transcriptional activation of latent Epstein-Barr virus
26. Three unrelated viral transforming proteins (vIRF, EBNA2 and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors
27. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 co-activator
28. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300
29. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA
30. Activation of integrated provirus requires histone acetyltransferase; p300 and P/CAF are coactivators for HIV-1 Tat
31. HIV-1 Tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter
32. HIV-1 Tat transcriptional activity is regulated by acetylation
33. Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr
34. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo
35. HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator
36. Regulation of gene expression by HTLV-1 Tax protein
37. p300 and p300/cAMP-responsive element-binding protein associated factor interact with human T-cell lymphotropic virus type-1 Tax in a multi-histone acetyltransferase/activator-enhancer complex
38. Inactivation of p53 by human T-cell lymphotropic virus type 1 Tax requires activation of the NF-κB pathway and is dependent on p53 phosphorylation
39. HTLV-I Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300
40. The p300/CBP family: integrating signals with transcription factors and chromatin
41. Targeting of transcriptional cofactors by the HPV E6 protein: another tale of David and Goliath